Svenska Handelsbanken AB Class B SHB_B
OMXSTO · Sweden · Finance
SEK 239.60+1.60 (+0.67%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Svenska Handelsbanken has delivered a strong run over the past few years, which puts fresh attention on what investors are really paying for. The core issue is whether the current share price lines up with the returns the bank earns on the capital it deploys. Over the past 5 years the stock has returned 157.4%, which raises the question of how closely that performance tracks the bank's underlying returns on equity and invested capital. The group relies heavily on disciplined lending and a...
The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 6 May 2026 resolved on a directed issue of redeemable and convertible class C shares and to authorise the Board of Directors to resolve on the repurchase of all issued class C shares through an acquisition offer directed to all owners of class C shares in Sobi. The Board of Directors of Sobi has, as previously communicated, on 15 July 2026 resolved to, conditional upon subscription and payment from Svenska Handelsbanken
Svenska Handelsbanken AB (SVNLF) reports solid operating profit and strong asset quality, despite facing margin pressures and increased regulatory fees.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.